Silk Road Medical PE Ratio 2018-2019 | SILK
Current and historical p/e ratio for Silk Road Medical (SILK) from 2018 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Silk Road Medical PE ratio as of February 28, 2020 is 0.00.
|Silk Road Medical PE Ratio Historical Data
||TTM Net EPS
||Medical Instruments Manufacturing
Silk Road Medical Inc. is a medical device company. It is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization. TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Silk Road Medical Inc. is based in Sunnyvale, California.